During the past decade, Heartland Oncology and Hematology LLP conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 6 clinical trials were completed. i.e. 54.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Heartland Oncology and Hematology LLP" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Canadian Cancer Trials Group" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heartland Oncology and Hematology LLP" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Heartland Oncology and Hematology LLP" are "Breast Cancer" (8 trials), "Lung Cancer" (3 trials), "Prostate Cancer" (3 trials), "Recurrent Lung Non-Small Cell Carcinoma" (3 trials) and "Stage IV Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Heartland Oncology and Hematology LLP" in a lesser frequency.

Most popular intervention types in "Heartland Oncology and Hematology LLP" are "Drug" (37 trials), "Other" (22 trials), "Biological" (14 trials), "Procedure" (12 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Quality-of-Life Assessment" (9 trials), "Biospecimen Collection" (8 trials), "Computed Tomography" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Heartland Oncology and Hematology LLP" are 29 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Heartland Oncology and Hematology LLP". undefined are not yet recruiting, 12 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Heartland Oncology and Hematology LLP, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Heartland Oncology and Hematology LLP, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".